Company snapshot
Market Cap
$10B
Large-cap2016 — today
10-Year Price
+263%
2016 — today
52-Week Range
$55.10$96.82
Current $74.19· 46%
Featured in rankings
Most Undervalued Healthcare StocksBest Healthcare GARP StocksMost Undervalued Value StocksMost Undervalued Growth StocksBest GARP Stocks (Growth at a Reasonable Price)Cheapest Large-Cap Stocks
Rankings recomputed after each US market close — see where GMED stands against peers.
Similar companies
| Company | P/E | Div yield |
|---|---|---|
| ZTSZoetis Inc. | 12.0 | 2.9% |
| ALCAlcon Inc. | 50.8 | 0.5% |
| CNCCentene Corporation | -6.4 | — |
| ALNYAlnylam Pharmaceuticals, Inc. | 42.0 | — |
| ONCBeOne Medicines Ltd. | 4.8 | — |
| IDXXIDEXX Laboratories, Inc. | 35.7 | — |
| AAgilent Technologies, Inc. | 28.9 | 0.5% |
| RVMDRevolution Medicines, Inc. | -23.0 | — |
Healthcare companies of comparable size — each one shown against its own 10-year range, not a sector average. Browse all stocks we cover.
Valuation in context
P/E ratio
19.1
Near historic low
Near historic low — last 10 years
Sector median 24.7below sector
P/B ratio
2.2
Historically cheap
Historically cheap relative to the last 10 years
Sector median 2.5below sector
EV / EBITDA
11.2
Near historic low
Near historic low — last 10 years
Sector median 15.2below sector
PEG ratio
1.1
Historically cheap
Historically cheap relative to the last 10 years
Sector median 1.5below sector
FCF Yield
7.3%
Near historic high
Near historic highs — last 10 years
Sector median -9.6%above sector